Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which IV iron works better for anemic pregnant women?

NCT ID NCT06061393

Symptom relief Sponsor: Western Galilee Hospital-Nahariya Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers compare two intravenous iron treatments, Ferinject and Venofer, in pregnant women with iron deficiency anemia and hemoglobin below 9 g/dL. The trial enrolls about 200 women past 24 weeks of pregnancy. It tracks hemoglobin levels at delivery and after birth, plus whether women need blood transfusions. The goal is to see which treatment more effectively raises hemoglobin and reduces transfusion needs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intravenous iron treatments Ferinject and Venofer
What this could lead to
If one IV iron treatment works better, it could guide doctors toward faster anemia correction and fewer blood transfusions for pregnant women.
What could go wrong
Both drugs are already used in pregnancy, so the trial may show similar results. IV iron can cause allergic reactions, and the findings may not apply to women with other types of anemia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: pregnancy\>24 weeks of gestation anemia with Hb\<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage Exclusion Criteria: * Allergy to one of the study's drugs * IV iron treatment in the last month * Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis * Twin pregnancy * non iron deficiency anemia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia, iron-deficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia, iron-deficiency Pregnancy anemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Galilee Medical Center

    RECRUITING

    Nahariya, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.